Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Interventional × Fluoxetine × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Exercise 432 Blood Specimen Collection 332 Standard of Care 317 Magnetic Resonance Spectroscopy 259 Radiotherapy 255 Radiosurgery 243 Surveys and Questionnaires 242 Educational Status 228 Methods 227 Early Intervention, Educational 216 Practice Guidelines as Topic 146 Biopsy 145 Interviews as Topic 141 Surgical Procedures, Operative 132 Drug Therapy 132 Control Groups 128 Acupuncture Therapy 123 Therapeutics 109 Cyclophosphamide 102 Counseling 100 Palliative Care 98 Resistance Training 94 Magnetic Resonance Imaging 89 Cisplatin 89 Saline Solution 88 Radiofrequency Ablation 85 Radiotherapy, Intensity-Modulated 79 Colonoscopy 79 Specimen Handling 75 Cognitive Behavioral Therapy 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00512291 2011-09-27

Subcutaneous Olanzapine for Hyperactive or Mixed Delirium

M.D. Anderson Cancer Center

Phase NA Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡